Reduced Intensity Haploidentical BMT for High Risk Solid Tumors (NCT01804634)
A Phase II Trial of Reduced Intensity Conditioning and Partially HLA-mismatched (HLA-haploidentical) Related Donor Bone Marrow Transplantation for High-risk Solid Tumors
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to see if giving reduced intensity chemotherapy, haploidentical bone marrow, post-transplant cyclophosphamide and shortened duration tacrolimus is safe and feasible for patients with very high-risk solid tumors.
Who can join: Review the eligibility criteria below.
Location: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland
Age range: 1 Year to 50 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland
- Albert Einstein College of Medicine, Children's Hospital at Montefiore — The Bronx, New York
- New York Medical Center/ Maria Fareri Children's Hospital — Valhalla, New York
📞 Contact the Study Coordinator
Phone: (410) 502-4997
Email: hsymons2@jhmi.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
- 💵 Compensation indicated: Growth factor support Patients will receive G-CSF (Filgrastim®) 5µg/kg/d SC or IV starting at Day 5 and continuing until the ANC\>1000/mm3 x 3days or two consecutive measurements over a three day ...
Explore by condition: All Refractory and/or Relapsed Metastatic Solid Tumors clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.